Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States: Trial N/A Recruiting Oct. 21, 2025
Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients. Trial Phase 2 Not yet recruiting Oct. 14, 2025
Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD Trial N/A Recruiting Oct. 14, 2025
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure Trial Phase 1 Recruiting Oct. 13, 2025
Cognitive Decline Following Deep Brain Stimulation: A DBS-fMRI Study Trial N/A Recruiting Oct. 13, 2025
Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis Trial Phase 2 Recruiting Oct. 13, 2025
Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD) Trial N/A Not yet recruiting Oct. 6, 2025
Molecular Imaging of Inflammation in Parkinson's Disease Using LPS and TSPO-PET/MR Trial N/A Recruiting Oct. 6, 2025
Observational Case Series of Patients With Parkinson's Disease (PD) Attending a Complementary Medicine Neuro-degenerative Disease (NDD) Clinic. Trial N/A Recruiting Oct. 2, 2025
Closed-Loop Therapeutic Refinement Using Local Field Potentials in Parkinson's Disease Trial N/A Not yet recruiting Oct. 2, 2025
Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform Trial Trial Phase 3 Recruiting Oct. 2, 2025
Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging Trial N/A Recruiting Sept. 30, 2025